Biocon Limited
BIOCON.NS
$-0.12
Change (1 day)
$4.71
Year High
$2.59
Year Low
Categories
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Biocon Limited (BIOCON.NS) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 741.89 M | 1.67 B | 3.67 B | 6.68 B | 1.81 B |
| 2022 | 433.85 M | 1.99 B | 3.52 B | 6.2 B | 1.47 B |
| 2021 | 436.37 M | 533.92 M | 1.3 B | 2.43 B | 998.1 M |
| 2020 | 325.27 M | 420.15 M | 1.19 B | 2.21 B | 904.99 M |
| 2019 | 199.92 M | 215.04 M | 840.73 M | 1.72 B | 634.06 M |